Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial

医学 内科学 非酒精性脂肪肝 胃肠病学 脂肪肝 丙氨酸转氨酶 天冬氨酸转氨酶 随机对照试验 瞬态弹性成像 中医药 转氨酶 肠道菌群 肝硬化 病理 疾病 碱性磷酸酶 免疫学 肝纤维化 生物 替代医学 生物化学 酶
作者
Qiaohong Liu,Xiaojing Li,Yuqing Pan,Qian Liu,Ying Li,Cong He,Ningning Zheng,Yan Wang,Huichao Wang,Yan Wang,Lili Sheng,Binbin Zhang,Tianbai Shen,Gaosong Wu,Houkai Li,Xiaosu Wang,Wei Zhang,Yiyang Hu,Yu Zhao
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:130: 155398-155398 被引量:33
标识
DOI:10.1016/j.phymed.2024.155398
摘要

BACKGROUND: The effective treatment of non-alcoholic fatty liver disease (NAFLD) is an unmet medical need. Qushi Huayu (QSHY) is an empirical herbal formula with promising effects in NAFLD rodent models and a connection to gut microbiota regulation. HYPOTHESIS/PURPOSE: This study aimed to evaluate the effects of QSHY in patients with NAFLD through a multicenter, randomized, double-blind, double-dummy clinical trial. STUDY DESIGN: A total of 246 eligible patients with NAFLD and liver dysfunction were evenly divided to receive either QSHY and Dangfei Liganning capsule (DFLG) simulant or QSHY simulant and DFLG (an approved proprietary Chinese medicine for NAFLD in China) for 24 weeks. The primary outcomes were changes in liver fat content, assessed using vibration-controlled transient elastography, and serum alanine aminotransferase (ALT) levels from baseline to Week 24. RESULTS: Both QSHY and DFLG led to reductions in liver fat content and liver enzyme levels post-intervention (p < 0.05). Compared to DFLG, QSHY treatment improved ALT (β, -0.128 [95 % CI, -0.25, -0.005], p = 0.041), aspartate transaminase (β, -0.134 [95 % CI, -0.256 to -0.012], p = 0.032), and fibrosis-4 score (β, -0.129 [95 % CI, -0.254 to -0.003], p = 0.044) levels. QSHY markedly improved gut dysbiosis compared to DFLG, with changes in Escherichia-Shigella and Bacteroides abundance linked to its therapeutic effect on reducing ALT. Patients with a high ALT response after QSHY treatment showed superior reductions in peripheral levels of phenylalanine and tyrosine, along with an elevation in the related microbial metabolite p-Hydroxyphenylacetic acid. CONCLUSION: Our results demonstrate favorable clinical potential for QSHY in the treatment of NAFLD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
刚刚
DaoXiaolang完成签到,获得积分10
1秒前
1秒前
1秒前
章鱼完成签到,获得积分10
1秒前
英吉利25发布了新的文献求助10
1秒前
1秒前
Wait完成签到,获得积分10
1秒前
Xiao完成签到,获得积分10
1秒前
aaa完成签到,获得积分10
2秒前
2秒前
曾经铅笔发布了新的文献求助10
2秒前
孙家贝发布了新的文献求助10
2秒前
2秒前
2秒前
张泽鑫发布了新的文献求助50
3秒前
ZT1发布了新的文献求助10
3秒前
Yoeyvol完成签到,获得积分10
3秒前
Mxy发布了新的文献求助10
3秒前
充电宝的应助被星河采纳,获得10
3秒前
glacier发布了新的文献求助10
3秒前
3秒前
xiaomiao发布了新的文献求助10
3秒前
榛子田发布了新的文献求助30
4秒前
Ying完成签到 ,获得积分10
4秒前
4秒前
爆米花的应助被简单晓博采纳,获得10
4秒前
Linn完成签到 ,获得积分10
4秒前
Lily发布了新的文献求助10
4秒前
wzm完成签到,获得积分10
4秒前
5秒前
6秒前
6秒前
Lu发布了新的文献求助10
6秒前
英吉利25发布了新的文献求助10
6秒前
大地完成签到,获得积分10
6秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572482
关于积分的说明 21825940
捐赠科研通 7780074
什么是DOI,文献DOI怎么找? 3433945
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480166